CS1:LSE:LSE-Amundi IBEX 35 UCITS ETF Acc GBP (GBX)

ETF | Others |

Last Closing

USD 27067.5

Change

+262.50 (+0.98)%

Market Cap

USD 0.10B

Volume

2.91K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+2.45 (+0.99%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+82.00 (+0.43%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.75 (-1.39%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.21 (+1.13%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.09 (+0.64%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-1.38 (-1.14%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.60 (+2.35%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.36 (+1.18%)

USD 260.39B
0QZO:LSE 0QZO

+0.85 (+0.86%)

USD 258.54B

ETFs Containing CS1:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.17% 93% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.17% 93% A 87% B+
Trailing 12 Months  
Capital Gain 27.15% 93% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.15% 92% A 86% B+
Trailing 5 Years  
Capital Gain 130.24% 83% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 130.24% 81% B- 82% B
Average Annual (5 Year Horizon)  
Capital Gain 14.13% 75% C 76% C+
Dividend Return 14.13% 74% C 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.87% 60% D- 76% C+
Risk Adjusted Return 119.03% 96% N/A 98% N/A
Market Capitalization 0.10B 49% F 27% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.